Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
SANOFI has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, ...
SANOFI has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, ...
A CHINESE drugmaker has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for its approval. Hangzhou ...
A DRUGMAKER in China has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for approval ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.